Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SciSparc (SPRC US)
Watchlist
83
Analysis
Health Care
•
Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Dusit Thani
•
08 Sep 2026 15:07
•
Broker
KTX Tactical Picks - September 8, 2026 (Eng.)
We recommend taking profit on IRPC after its holding-period return surged to +22.1%, and adding THANI to the portfolio as a replacement. Our...
Krungthai XSpring
Follow
92 Views
Share
bearish
•
Cross Asset Strategy
•
26 Jul 2024 10:12
•
Broker
Keep a Close Watch on US Inflation and Thai Corporate Earnings
Technically, the SET Index is expected to move sideways, with the support at 1,286/1,281 points and the resistance at 1,301/1,309 points (10-day...
Krungthai XSpring
Follow
90 Views
Share
bearish
•
Samart Aviation Solutions Public Co Ltd
•
02 Sep 2026 10:38
•
Broker
Krungthai XSpring Zoom Eng. September 2, 2026
Global financial markets closed in risk-off mode after the 10-year US Treasury yield surged to 4.80%, its highest level in three years. Brent...
Krungthai XSpring
Follow
91 Views
Share
bearish
•
Global Power Synergy
•
26 Jan 2024 10:03
•
Broker
Technical Analysis
Most Asian bourses continued to advance thanks to China's economic stimulus while investors awaited the US GDP figure. The index was unable to run...
Krungthai XSpring
Follow
83 Views
Share
bearish
•
Macroeconomics
•
06 Nov 2023 18:46
•
Broker
Monthly Report: November 2023: Outlook: To Fall Further (With Some Rebounds), With the Support at 1,350/1,320 Points and the Resistance at 1,400/1,420 Points
KTX expects the SET Index to fall further (with some rebounds), with the support at 1,350/1,320 points and the resistance at 1,400 1,420 points,...
Krungthai XSpring
Follow
89 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x